Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v1-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated | 2026-04-20 | 2026-04-20 |
| Drug Identification Number | 02522403 | 02522403 |
| Brand name | VAXNEUVANCE | VAXNEUVANCE |
| Common or Proper name | Pneumococcal 15-valent conjugate vaccine | Pneumococcal 15-valent conjugate vaccine |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F |
| Strength(s) | 2MCG 2MCG 2MCG 2MCG 30MCG 4MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG | 2MCG 2MCG 2MCG 2MCG 30MCG 4MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG 2MCG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 10 DOSE | 10 DOSE |
| Additional packaging sizes | ||
| ATC code | J07AL | J07AL |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2026-04-20 | 2026-04-20 |
| Actual start date | 2026-04-20 | 2026-04-20 |
| Estimated end date | 2026-04-24 | 2026-04-24 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |